Low T Testosterone Therapy Linked to Stroke and Heart Problems

 Posted on May 05, 2014 in Defective Medical Devices

The FDA recently launched a comprehensive investigation into the “low T” testosterone therapy program. Early research indicates that men may face a higher risk of premature death, stroke, or heart attacks by undergoing this therapy. This is just the latest in a string of defective medical devices and treatments, being investigated by the government, that end up harming patients. For some patients, it is too little, too late.

The evaluation of the therapy was launched after two large studies were found to increase the likelihood of a cardiovascular incident. The federal agency is now exploring whether the possible benefits of the therapy are outweighed by the potential negative impacts on the male patients who use it. At present, these drugs are only advised for men who have low T and a linked medical condition. However, research shows that some men may be undergoing the therapy without actually needing it.

One of the studies spurring the investigation found that within 90 days of starting the therapy, heart attack risks could be doubled in men aged 65 and over, tripling the risk for younger men with a known heart condition. A previous study found that there were increases of up to 30 percent for heart attacks, strokes, and death in men over the age of 60 who were using low T testosterone therapy.

Since the therapy is relatively new, there are no long-term studies about the impacts of undergoing the treatment. Early research already indicates that there are risks for undergoing the therapy specifically with regard to heart issues, and some advocates are calling for additional studies with more participants. In the short term, all patients who have used this therapy should continue to keep tabs on research coming out about this therapy. If you have been injured by a device or treatment already, contact an Illinois defective medical device attorney today.